Pioglitazone Hydrochloride (Actos(Registered Trademark)) to Treat Asthma

Clinical trial NCT00604578 · WITHDRAWN

Trial details

NCT number: NCT00604578
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Asthma Airway Inflammation Airflow Obstruction Airway Hyperactivity

Start date: 2008-01-04
Primary completion: 2009-10-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.